Capital Flow Monitor · Sponsors · CIK 1880438
AN2 Therapeutics, Inc.
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025 · (650) 331-9090
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$40.0M
Sold
$40.0M
% sold
100.0%
Investors
16
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-25 | D ·current | 506(b) | $40.0M | $40.0M | 100.0% | 16 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Eric Easom — Executive Officer / Director, MENLO PARK, CA
- Joshua Eizen — Executive Officer, MENLO PARK, CA
- Lucy Day — Executive Officer, MENLO PARK, CA
- Sanjay Chanda — Executive Officer, MENLO PARK, CA
- Joseph S. Zakrzewski — Director, MENLO PARK, CA
- Kabeer Aziz — Director, MENLO PARK, CA
- Rob Readnour — Director, MENLO PARK, CA
- Gilbert Lynn Marks — Director, MENLO PARK, CA
- Stephanie Wong — Director, MENLO PARK, CA
- Patricia Martin — Director, MENLO PARK, CA
- Melvin Spigelman — Director, MENLO PARK, CA
- Margaret FitzPatrick — Director, MENLO PARK, CA
Placement agents
- Leerink Partners Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.